Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × UNKNOWN × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Clear all

Phase

Status

Sponsor Class

INDUSTRY 16 OTHER 11 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Uterine Cervical Neoplasms 1 Philadelphia Chromosome 1 Papillomavirus Infections 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Dwarfism 1 Breast Neoplasms 1

Interventions

Growth Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01901666 2013-07-17

Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission

PIMERIndia

Phase 4 Unknown

MyeloidOther hematologic neoplasm

Dwarfism, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡